Trial Profile
A head-to-head randomized clinical trial of methylphenidate and lisdexamphetamine treatment for executive functions and global functioning in adults with ADHD
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 28 Nov 2018 This study has been discontinued in Sweden.
- 08 Nov 2018 New trial record